Trusted Resource for Clinical Trials, Protocols & Progress
Red Flags in Vendor Risk Assessment Identifying Red Flags in Vendor Risk Assessments for Clinical Trials Introduction: Why Detecting Red Flags Matters Vendor risk assessments are critical to ensuring compliance, data integrity, and patient safety in clinical trials. Sponsors rely on CROs, central labs, IT vendors, and other partners, but not all vendors are equally…
How to Evaluate Vendor Financial Stability Evaluating Financial Stability of Vendors in Clinical Trials Introduction: Why Financial Stability Matters When outsourcing critical trial functions to vendors such as CROs, central laboratories, or eClinical providers, sponsors must ensure not only technical and regulatory competence but also financial stability. A vendor’s financial weakness can cause disruptions, missed…
How to Build a Risk Mitigation Plan for Clinical Trial Study Supplies Creating an Effective Risk Mitigation Plan for Clinical Trial Study Supplies In clinical trials, the uninterrupted availability of investigational products (IPs), lab kits, and ancillaries is vital for protocol adherence and subject safety. A delay, deviation, or disruption in the clinical supply chain…
Read More “How to Build a Risk Mitigation Plan for Clinical Trial Study Supplies” »
Vendor Consolidation Through FSP Strategy in Clinical Trials Streamlining Clinical Trial Outsourcing with FSP-Based Vendor Consolidation Pharmaceutical and biotech companies often face complexity in managing dozens of external vendors for clinical trials—ranging from CROs to niche functional providers. This fragmented model leads to inconsistent quality, duplicated oversight efforts, and uncontrolled costs. A Functional Service Provider…
Read More “Vendor Consolidation Through FSP Strategy in Clinical Trials” »
